Advanced in Developmental Dysphasia Familial

Daniela Berg

Arnold Heller Str. 3, 
Kiel, SH, DE 
Advanced in Developmental Dysphasia Familial
Arnold Heller Str. 3, 
Kiel, SH, DE 
OverviewLocationsClinical Research

Overview

Daniela Berg practices in Kiel, Germany. Ms. Berg is rated as an Advanced expert by MediFind in the treatment of Developmental Dysphasia Familial. Her top areas of expertise are Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Deep Brain Stimulation, and Thrombectomy.

Her clinical research consists of co-authoring 450 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 14 articles in the study of Developmental Dysphasia Familial.

Gender
Female

Locations

Arnold Heller Str. 3, Kiel, SH 24105, Germany
Other Locations
Hoppe Seyler Str. 3, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Rostock International Parkinson's Disease Study: an International, Multicenter, Epidemiological Observational Study
Rostock International Parkinson's Disease Study: an International, Multicenter, Epidemiological Observational Study
Enrollment Status: Active_not_recruiting
Publish Date: September 20, 2024
A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease
A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease
Enrollment Status: Completed
Publish Date: April 10, 2024
Intervention Type: Drug
Study Phase: Phase 2
The Parkinson's Progression Markers Initiative (PPMI)
The Parkinson's Progression Markers Initiative (PPMI)
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: DaTscan
Study Phase: Phase 2
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease. European Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease. European Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Drug
Study Drug: Deferiprone
Study Phase: Phase 2
View 3 Less Clinical Trials

449 Total Publications

Differences in intestinal microbiota in Parkinson's disease and isolated REM sleep behavior disorder.
Differences in intestinal microbiota in Parkinson's disease and isolated REM sleep behavior disorder.
Journal: Journal of Parkinson's disease
Published: September 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Berg's expertise for a condition
ConditionClose
View All 18 Advanced Conditions
View All 28 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile